IMUGENE LIMITED — Share Issue/Capital Change 2022

Jan 9, 2022

==> picture [116 x 42] intentionally omitted <==

ASX Announcement

Release of Shares from Escrow

---

SYDNEY, Australia, 10 January 2022: Imugene Limited (ASX:IMU), an immuno-oncology company, in accordance with ASX listing rule 3.10A, advises that 25,183,871 ordinary fully paid shares (ASX:IMU) will be released from voluntary escrow on 17 January 2022.

Phillip Hains

Joint Company Secretary.

IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com